Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-11

Clinical Trial Update: Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing bioequivalence between sodium valproate and valproic acid tablets for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium valproate (valproate)
  • VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Kathmandu University | Conditions: Epilepsy | Phase 4 | Status: UNKNOWN